Quince Therapeutics Announces Pricing Of Up To $22 Mln Private Placement Of Securities
June 12 (Reuters) - Quince Therapeutics Inc QNCX.O:
QUINCE THERAPEUTICS ANNOUNCES PRICING OF UP TO $22 MILLION PRIVATE PLACEMENT OF SECURITIES
QUINCE THERAPEUTICS INC - FINANCING TO PROVIDE $11.5 MILLION UPFRONT, $10.4 MILLION FROM WARRANTS
QUINCE THERAPEUTICS INC - PROCEEDS TO FUND PHASE 3 NEAT TRIAL AND CORPORATE PURPOSES
QUINCE THERAPEUTICS INC - PROCEEDS EXPECTED TO FUND OPERATIONS INTO SECOND QUARTER 2026
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Meme Stocks Reappear. Avis Shares Reach New Highs Amid Short Squeeze. Can Retail Investors Still Buy?

SpaceX IPO: Musk Weighs $60 Billion Cursor Deal, and Can It Save xAI?

Intel Q1 2026 Earnings Preview: The Rally is Ahead of the Fundamentals

SK Hynix Q1 2026 Earnings Preview: Memory Chip Prices Surge, Profit Set to Double

Intel Foundry Gains ‘High-Profile’ Customer, Tesla Becomes First Major Customer for 14A Technology

Tradingkey






